A new study led by researchers from Mayo Clinic is investigating artificial intelligence (AI) and brain waves for the early diagnosis of neurodegenerative diseases.
StartUp Breeze is a light and refreshing journey together with an extended network of partners helping focusing and improving the value proposition of business ideas and startups in pharma, medical devices digital health
AGEVITY is an initiative born from the Silver Economy Network with the support of Assolombarda, to promote dialogue among the key actors of the longevity economy, through the sharing of needs, opportunities, and best practices.
A highly curated event, gathering ecosystem leaders - founders, C-Suite executives and senior government and academic thought leaders and change makers - to discuss next frontier of innovation in health and life sciences.
In Europa esistono più quadri normativi sulle terapie digitali. I Paesi che hanno dato una svolta al comparto sono stati la Germania (pioniera), seguita da Francia, Belgio e UK. L’obiettivo, nei prossimi anni, è avere un quadro unico. Nel frattempo, Londra apre a nuovi iter.
La rapida evoluzione dei modelli di intelligenza artificiale generativa, come ChatGPT di OpenAI, segna un’era promettente per la ricerca medica. Un articolo pubblicato recentemente su The Lancet Digital Health esplora l’integrazione e le sfide dei large language models (LLM) nella patologia digitale, un campo in rapida evoluzione che richiede una comprensione contestuale complessa.
Researchers from the Massachusetts Institute of Technology (MIT) and ETH Zurich have developed an artificial intelligence (AI) model that can identify certain breast cancer stages and determine whether it is likely to progress into invasive cancer.
L’Agenzia per l’Italia Digitale (AGID) e il Dipartimento per la Trasformazione Digitale della Presidenza del Consiglio dei Ministri hanno recentemente pubblicato la “Strategia Italiana per l’Intelligenza Artificiale 2024-2026“. Questo documento strategico delinea una visione per posizionare l’Italia come leader nell’innovazione guidata dall’Intelligenza Artificiale.
Researchers from the University of Cambridge’s department of psychology have revealed that their artificial intelligence tool for predicting early Alzheimer’s disease (AD) more accurately detected the condition compared to current clinical tests.
Preferences
Would you like to share some personal information with us so we can improve your experience on Researchalize.org?
